Companies / LLY vs MRK
LLY vs MRK: Eli Lilly and Merck
Eli Lilly (LLY) reported $65.2B in revenue against a 31.7% net margin, while Merck (MRK) reported $65.0B at a 28.1% net margin, most recently.
| Metric | LLY | MRK |
|---|---|---|
| Revenue | $65.2B | $65.0B |
| Net Income | $20.6B | $18.3B |
| Gross Margin | 83.0% | 74.8% |
| Operating Margin | — | — |
| EPS (Diluted) | $22.95 | $7.28 |
| Free Cash Flow | — | $12.4B |
| Total Debt | $42.5B | $49.3B |
| P/E Ratio | 46.9× | 14.5× |
| P/B Ratio | n/m | n/m |
| Stock Price | $1375.19 | $147.90 |
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| MRK Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |